Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
In (almost) his first full year on the job as CEO of $LSTR, Frank Lonegro had total comp of $13.37 mil. That included a stock award of about $11.4 mil. Predecessor James Gattoni, in his last full year as CEO in '23, had total comp of $2.43 mil. A year earlier it was $4.57 mil. https://t.co/TgCOxZXtow
T. Rowe Price just gave its CEO a huge raise to keep up with the Joneses https://t.co/ZO6x0HL5pe
RxSight lowers FY25 outlook, shares drop 📉 RxSight $RXST shares fell after the company cut its FY25 revenue forecast, citing challenges in the premium cataract market. 🔹 Q1 revenue: $37.9M (+28% YoY) but below estimates 🔹 Revised FY25 revenue outlook: $160M–$175M (vs. https://t.co/sqCr39cJFf
RxSight, Inc. reported preliminary revenue of $37.9 million for the first quarter of 2025, reflecting a 28% increase year-over-year but a 6% decrease sequentially. The company has revised its full-year 2025 revenue guidance to a range of $160 million to $175 million, down from the previous estimate of $185 million to $197 million. This adjustment suggests an anticipated growth of 14% to 25% over 2024. The announcement has led to a significant decline in RxSight's stock, which fell by 28.6% in pre-market trading. The company cited challenges in the premium cataract market as a contributing factor to its lowered outlook.
